Drug Trial Radar · NCT07794774
A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
197
Planned (sponsor's estimate)
Start
Sep 29, 2026
Primary completion
Feb 21, 2029
Study completion Feb 21, 2029
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 31, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to learn about safety and effects of berobenatide (PF-08653944) in adults with obesity disease, a condition in which a person has too much body fat, which can harm their health and increase the risk of other medical problems. Some participants in this study may also have type 2 diabetes, a condition in which the body does not use insulin properly, causing blood sugar levels to become too high. This study is seeking participants in Japan who: * Have obesity disease. * May have type 2 diabetes. * Meet the study-specific age, weight, and health requirements. About 197 adults will take part in this study. Participants will be randomly assigned to receive either berobenatide or a placebo. A placebo looks like the study medicine but does not contain any active medicine. Berobenatide or placebo will be given as an injection under the skin of the abdomen (belly area). The study will compare the experiences of people receiving berobenatide with those receiving placebo to determine whether berobenatide can help people lose weight. The study will also assess the safety of berobenatide and its effects on body weight and other health measures. People will take part in this study for about 21 months. During this time, they will have about 16 study visits at the site. They will also have 2 study visits over the phone.
Conditions
- Obesity
Interventions
BerobenatideDrug
Subcutaneous Injection
PlaceboOther
Subcutaneous Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in body weightTime frame: Baseline, Week 72
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Nihonbashi Sakura Clinic
Tokyo, Japan · Recruiting
Tokuyama Clinic
Mihama-ku, Chiba, Japan · Recruiting
Mikannohana Clinic, Diabetes, Endocrinology and Metabolism
Matsuyama, Ehime, Japan · Recruiting
Matsuyama Shimin Hospital
Matsuyama, Ehime, Japan · Recruiting
Tenjin Sogo Clinic
Fukuoka, Fukuoka, Japan · Recruiting
Medical Corporation BOOCS BOOCS CLINIC FUKUOKA
Fukuoka, Fukuoka, Japan · Recruiting
Fukuoka Diagnostic Imaging Clinic Me-Well
Fukuoka, Fukuoka, Japan · Recruiting
Oishi Clinic
Kasuya-gun, Fukuoka, Japan · Recruiting
Manda Memorial Hospital
Sapporo, Hokkaido, Japan · Recruiting
Yamasaki Family Clinic
Amagasaki, Hyōgo, Japan · Recruiting
Minami Akatsuka Clinic
Mito, Ibaraki, Japan · Not yet recruiting
Mito Saiseikai General Hospital
Mito, Ibaraki, Japan · Not yet recruiting
Nishiyamado Keiwa Hospital
Naka, Ibaraki, Japan · Recruiting
Olive Takamatsu Medical Clinic
Takamatsu, Kagawa-ken, Japan · Recruiting
Medical Corporation Hitomikai Motomachi Takatsuka Naika Clinic
Yokohama, Kanagawa, Japan · Recruiting
Yokoi Clinic
Minoh, Osaka, Japan · Recruiting
Kanemura Clinic
Osaka-shi Ikuno-ku, Osaka, Japan · Recruiting
Medical Corporation Heishinkai OCROM Clinic
Suita, Osaka, Japan · Recruiting
MI Clinic, Medical Corporation Jinsenkai
Toyonaka-shi, Osaka, Japan · Recruiting
Soka Sugiura Internal medicine Clinic
Soka-shi, Saitama, Japan · Recruiting
Saiyu Soka Hospital
Soka-shi, Saitama, Japan · Recruiting
Doujin Memorial Foundation Meiwa Hospital
Chiyoda-ku, Tokyo, Japan · Recruiting
Aic Yaesu Clinic
Chuo-ku, Tokyo, Japan · Recruiting
Tokyo Center Clinic
Chuo-ku, Tokyo, Japan · Recruiting
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, Japan · Recruiting
Fukuwa Clinic
Chuo-ku, Tokyo, Japan · Recruiting
Tokyo Asbo Clinic
Chuo-ku, Tokyo, Japan · Recruiting
Keikokai Medical Corporation P-one Clinic
Hachiōji, Tokyo, Japan · Recruiting
Medical Corp. Seikoukai New Medical Research System Clinic
Hachioji-shi, Tokyo, Japan · Recruiting
Hachioji Clinic Shincho
Hachioji-shi, Tokyo, Japan · Recruiting
Patient First Clinic Ginza-Shimbashi
Minato-ku, Tokyo, Japan · Recruiting
Shimamura Memorial Hospital
Nerima-ku, Tokyo, Japan · Recruiting
Medical Corporation Heishinkai ToCROM Clinic
Shinjuku-ku, Tokyo, Japan · Recruiting
Seeds Clinic Shinjuku-Sanchome, Eijinkai Medical Corporation
Shinjuku-ku, Tokyo, Japan · Recruiting
Higashi-Shinjuku Clinic, Keikokai Medical Corp.
Shinjuku-ku, Tokyo, Japan · Recruiting
Ikebukuro Metropolitan Clinic
Toshima-ku, Tokyo, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.